Institutional Manager · CIK 0001395064
TAKEDA PHARMACEUTICAL CO LTD
Tokyo, M0 · File #028-24938
Latest AUM
$16.4M
Positions
9
Top-10 Concentration
100.0%
Filings
8
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Sep 20259 pos · $16.4M
- 13F HOLDINGS REPORTQ/E Jun 202512 pos · $19.6M
- 13F HOLDINGS REPORTQ/E Mar 202512 pos · $16.2M
- 13F HOLDINGS REPORTQ/E Dec 202416 pos · $327.5M
- 13F HOLDINGS REPORTQ/E Dec 202417 pos · $289.0M
- 13F HOLDINGS REPORTQ/E Dec 202412 pos · $38.0M
- 13F HOLDINGS REPORTQ/E Dec 202415 pos · $232.3M
- 13F HOLDINGS REPORTQ/E Dec 202412 pos · $26.6M
Top 9 Holdings — Sep 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Ovid Therapeutics, Inc. | OVID | 5,750,000 | $7.5M | 45.67% |
| 2 | Equillium, Inc. | EQ | 1,824,977 | $2.6M | 15.94% |
| 3 | Ovid Therapeutics, Inc. | OVID | 1,781,996 | $2.3M | 14.15% |
| 4 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | XLO | 1,475,121 | $1.2M | 7.59% |
| 5 | Shattuck Labs, Inc. | STTK | 515,619 | $1.2M | 7.53% |
| 6 | Lyell Immunopharma, Inc. | LYEL | 54,887 | $891,365 | 5.45% |
| 7 | American Well Corporation | AMWL | 77,733 | $478,061 | 2.92% |
| 8 | Rani Therapeutics Holdings, Inc. | RANI | 203,190 | $101,554 | 0.62% |
| 9 | Standard Biotools, Inc. | LAB | 16,515 | $21,470 | 0.13% |